̖(ho) | ˎƷQ | ͨ | a(chn) | Ҏ(gu) | λ | r(ji) |
111004 | Z`A(y)Pо | ϳȍuעҺ(A(y)30R) | Novo Nordisk Pharmaceutical Industries | 3ml:300HλPо | ֧ | 70 |
111006 | Z` | ϳȍuעҺ(A(y)50R) | Novo Nordisk A/S | 300IU:3ml(Pо) | ֧ | 73 |
111008 | Z`ЧPо | ϳȍuעҺ | Novo Nordisk Pharmaceutical Industries,Inc. | 300IU/3ml/֧(Pо) | ֧ | 73 |
111017 | ZJ | Tȍu30עҺ | Novo Nordisk A/S | 100U/mL*3mL*5֧ | 578 | |
111007 | Z` | ϳȍuעҺ | Novo Nordisk A/S | 400IU/10ml | ƿ | 73 |
111005 | Z` | ϳȍuעҺ(A(y)30R) | Novo Nordisk A/S | 300IU/3ml/֧س䣩 | ֧ | 92 |
111009 | Z` | ϳȍuעҺ | Novo Nordisk A/S | 300IU/3ml/֧س䣩 | ֧ | 90 |
111745 | (yu)Ч | ؽMȍuעҺ | Lilly Egypt | 10ml:400IU | ƿ | 65 |
111746 | (yu)Ч | ؽMȍuעҺ | Lilly France S.A. | 100IU/ml*3mL | ֧ | 65 |
111003 | Z` | ϳȍuעҺ | Novo Nordisk A/S | 40 IU/ml10ml/ƿ | ƿ | 73 |
111740 | (yu) | ؽMȍuעҺ | Y˾ | 40 u/mL x 10 mL | ֧ | 65 |
һ 1 һ β 퓴Σ1/1 50ƪ/ D(zhun) |